Growth Metrics

Vycor Medical (VYCO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Vycor Medical - - 375,153.00 29.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 29.23%
Dec 31, 2025 -830.47%
Sep 30, 2025 29.17%
Jun 30, 2025 337.97%
Mar 31, 2025 -4.13%
Dec 31, 2024 92.76%
Sep 30, 2024 -3.70%
Jun 30, 2024 -114.67%
Mar 31, 2024 -24.12%
Dec 31, 2023 20.16%
Sep 30, 2023 22.71%
Jun 30, 2023 169.09%
Mar 31, 2023 34.39%
Dec 31, 2022 37.70%
Sep 30, 2022 -74.77%
Jun 30, 2022 -956.22%
Mar 31, 2022 41.56%
Dec 31, 2021 6.64%
Sep 30, 2021 56.03%
Jun 30, 2021 96.23%
Mar 31, 2021 -20.16%
Dec 31, 2020 9.34%
Sep 30, 2020 3.05%
Jun 30, 2020 -34.31%
Mar 31, 2020 1.56%
Dec 31, 2019 54.15%
Sep 30, 2019 -18.27%
Jun 30, 2019 55.73%
Mar 31, 2019 29.94%
Dec 31, 2018 -28.48%
Sep 30, 2018 46.77%
Jun 30, 2018 -16.04%
Mar 31, 2018 -2.91%
Dec 31, 2017 23.04%
Sep 30, 2017 -39.52%
Jun 30, 2017 -18.13%
Mar 31, 2017 22.88%
Sep 30, 2016 28.51%
Jun 30, 2016 27.34%
Mar 31, 2016 23.65%
Sep 30, 2015 55.98%
Jun 30, 2015 67.13%
Mar 31, 2015 -2.36%
Sep 30, 2014 -159.54%
Jun 30, 2014 -98.99%
Mar 31, 2014 -18.91%
Dec 31, 2013 -15.00%
Sep 30, 2013 33.99%
Jun 30, 2013 19.47%
Mar 31, 2013 15.41%
Dec 31, 2012 36.84%
Sep 30, 2012 31.67%
Jun 30, 2012 56.53%
Mar 31, 2012 16.27%
Dec 31, 2011 0.76%
Sep 30, 2011 -221.88%
Jun 30, 2011 -336.77%